The panel, titled The Power of Diagnostics: How Delays Impact Patients and Providers, featured clinical leaders from UCLA and Seattle Children’s Hospital alongside representatives from HealthyWomen. Discussions centered on the tangible risks of diagnostic lag, where patients often fail to return for follow-up care if answers are not provided during an initial visit. Dr. Charles K. Cooper, Chief Medical Officer at bioMérieux, emphasized that rapid diagnostic access is essential to alleviating the mounting stress on clinicians and their patients.
In section Releases
bioMérieux Champions Rapid Diagnostics at ADLM 2026
Delayed test results create a cascade of clinical failures, leaving patients without treatment and burdening already strained healthcare systems. At the 2026 Association for Diagnostics & Laboratory Medicine conference in Anaheim, bioMérieux convened experts to examine how point-of-care testing serves as a critical pressure valve for modern medicine.
Helaine Bader of HealthyWomen noted that immediate diagnostics not only mitigate potential infection complications but also fortify the fragile trust between providers and patients. Beyond the clinical discourse, the company secured seven 2026 IMV ServiceTrak Clinical Laboratory Awards, marking the ninth consecutive year of industry recognition for its diagnostic support and system performance. These honors, spanning immunoassay, blood culture, and ID/AST systems, underscore the firm's ongoing efforts to address sepsis and antimicrobial resistance through high-speed, accurate testing.
Comments (0)
No comments yet. Be the first!